Antiviral role of nanomaterials: a material scientist's perspective

Citations

WEB OF SCIENCE

10
Citations

SCOPUS

13

초록

The present world continues to face unprecedented challenges caused by the COVID-19 pandemic. Collaboration between researchers of multiple disciplines is the need of the hour. There is a need to develop antiviral agents capable of inhibiting viruses and tailoring existing antiviral drugs for efficient delivery to prevent a surge in deaths caused by viruses globally. Biocompatible systems have been designed using nanotechnological principles which showed appreciable results against a wide range of viruses. Many nanoparticles can act as antiviral therapeutic agents if synthesized by the correct approach. Moreover, nanoparticles can act as carriers of antiviral drugs while overcoming their inherent drawbacks such as low solubility, poor bioavailability, uncontrolled release, and side effects. This review highlights the potential of nanomaterials in antiviral applications by discussing various studies and their results regarding antiviral potential of nanoparticles while also suggesting future directions to researchers.

키워드

SOLID LIPID NANOPARTICLESINFLUENZA-VIRUS INFECTIONFUNCTIONALIZED SELENIUM NANOPARTICLESSYNTHESIZED SILVER NANOPARTICLESLOADED LACTOFERRIN NANOPARTICLESCELLULOSE-ACETATE BUTYRATEIN-VITROCHITOSAN NANOPARTICLESDRUG-COMBINATIONDELIVERY-SYSTEM
제목
Antiviral role of nanomaterials: a material scientist's perspective
저자
Ali, Muhammad AanishRehman, NaginaPark, Tae JooBasit, Muhammad Abdul
DOI
10.1039/d2ra06410c
발행일
2022-12
유형
Review
저널명
RSC Advances
13
1
페이지
47 ~ 79